FerroKin Biosciences, Inc.: Series B $12M

Posted in I - Series B, Q - 2Q10, R - WEST, X - Anemia, XX - CA

FerroKin Biosciences (San Carlos, CA) a preclinical-stage biopharmaceutical company focused on iron chelator for treatment of anemia, closed a $12M Series B financing. Participants include Clarus Ventures, Burrill & Co., Celegene, MP Healthcare Venture Management and Healthcap Ventures.

Sep

2009

Akebia Therapeutics, Inc.: Series A $16M

Posted in I - Series A, Q - 3Q09, R - MID WEST, X - Anemia, X - Vascular, XX - OH

Akebia Therapeutics (Cincinnati, OH) a clinical-stage biopharmaceutical company focused on the development of small-molecules for anemia and vascular disease, closed a $16M Series A bringing the total financing to $25M. Participants include Novartis Venture Fund, Venture Investors, Triathlon Medical Ventures, Kearny Venture Partners, Athenian Venture Partners and Sigvion Capital.

Dec

2008

FerroKin Biosciences, Inc.: Series A $15

Posted in I - Series A, Q - 4Q08, R - WEST, X - Anemia

FerroKin Biosciences (San Carlos, CA) early-stage developer of iron chelator for treatment of anemias, closed a $15M Series A financing. Participants include Clarus Ventures, Burrill & Co. and Celegene Inc.

to top of page...